|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
5R21CA216756-02
|
$224,460
|
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
5R01CA184804-03
|
$387,731
|
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
Training in Interprofessional Education for Palliative Care in Oncology
|
5R25CA203637-02
|
$293,452
|
|
PFEIFER, MARK
|
UNIVERSITY OF LOUISVILLE
|
|
The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis
|
5F31CA196231-04
|
$31,044
|
$31,044
|
LIGGETT, LUTHER
|
UNIVERSITY OF COLORADO DENVER
|
|
The role of butyrate-producing bacteria in CIMP colorectal cancer tumorigenesis
|
5R01CA205028-02
|
$373,092
|
|
WILLIAMS, BRENT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Functional Role of GRM3 in Colon Cancer
|
5R01CA215389-02
|
$344,269
|
|
WANG, JING
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
The Effect Of Cohesin Mutations In Hematologic Malignancies
|
5F31CA216976-02
|
$38,609
|
$38,609
|
MCNULTY, MAUREEN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling
|
5R01CA217207-02
|
$489,796
|
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-06
|
$346,525
|
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Targeting Chromatin Modifications in Leukemia with Trisomy 21
|
5K08CA181340-05
|
$128,526
|
$64,263
|
LANE, ANDREW
|
DANA-FARBER CANCER INST
|
|
Targeting cell metabolism for preventing and treating metastatic colon cancer
|
5R21CA216604-02
|
$207,495
|
|
JIN, SHENGKAN VICTOR
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
|
Sphingosine-1-phosphate receptor subtype 3 in oncogenic K-Ras mutant-driven lung adenocarcinoma
|
5R21CA216650-02
|
$215,985
|
|
LEE, MENQ-JER
|
WAYNE STATE UNIVERSITY
|
|
Self-assembled multifunctional aptamer-complex biomaterial for precision medicine
|
1R01CA224304-01
|
$369,431
|
|
ZU, YOULI
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
Role of the microbiota in DNA methylation and CRC development
|
1R01CA214005-01A1
|
$567,545
|
|
ISSA, JEAN-PIERRE
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
Role of long non-coding RNAs in sarcoma pathogenesis
|
5R01CA211657-02
|
$400,745
|
|
SWEET-CORDERO, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Regulation of Colon Cancer by AIM2
|
1K22CA212030-01A1
|
$159,549
|
|
WILSON, JUSTIN
|
UNIVERSITY OF ARIZONA
|
|
Programmable Probiotics for Cancer
|
5R00CA197649-04
|
$181,689
|
|
DANINO, TAL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Pancreatic Cancer Cell Mechanics and Imaging
|
5R01CA186286-05
|
$426,010
|
|
KONSTANTOPOULOS, KONSTANTINOS
|
JOHNS HOPKINS UNIVERSITY
|
|
New mechanisms of acquired resistance to EGFR-TKIs in Non-small-cell lung cancer
|
1K99CA215316-01A1
|
$98,086
|
|
HE, JUN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Molecular Mechanism and Therapy for Ocular Melanoma
|
5R01CA217642-02
|
$488,005
|
|
ZHANG, KANG
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Molecular imaging-directed bioengineering of nanoconjugates as adaptable tumor targeting platforms
|
1K99CA215301-01A1
|
$179,280
|
|
OBAID, GIRGIS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular diagnostic and prognostic signatures for PTCL
|
5UH2CA206127-02
|
$191,615
|
|
IQBAL, JAVEED
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
|
5R01CA202763-03
|
$483,484
|
|
SELVARAJ, PERIASAMY
|
EMORY UNIVERSITY
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
5R01CA101774-16
|
$337,725
|
$337,725
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Mechanism-based drug repurposing and novel treatments for glioblastoma
|
5R01CA214066-02
|
$352,275
|
|
NOBLE, MARK
|
UNIVERSITY OF ROCHESTER
|
|
Manipulation of Tumor Specific Immunity
|
5R01CA022677-37
|
$288,325
|
|
SCHREIBER, HANS
|
UNIVERSITY OF CHICAGO
|
|
Immunization Against Melanoma Differentiation Antigens
|
5R01CA056821-24
|
$299,950
|
|
WOLCHOK, JEDD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
High Performance, Quantitative Breast PET Scanner Integrated with Tomosynthesis
|
5R01CA196528-03
|
$637,215
|
|
SURTI, SULEMAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Generalized waveform methods for breast viscoelasticity mapping
|
5R01CA174723-05
|
$318,834
|
|
FATEMI, MOSTAFA
|
MAYO CLINIC ROCHESTER
|
|
Gene Dependent Cancer Risk and Optimal Cancer Prevention Strategies in Lynch Syndrome
|
1K07CA216326-01A1
|
$173,880
|
|
SHARAF, RAVI
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation
|
5R01CA207236-02
|
$546,754
|
|
PIWNICA-WORMS, HELEN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
F-Box Proteins: Deregulated Cell Cycle Control and Proteolysis in Cancer
|
5R01CA076584-20
|
$464,613
|
|
PAGANO, MICHELE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
|
5R01CA198128-03
|
$390,636
|
|
WILLIAMS, TERENCE
|
OHIO STATE UNIVERSITY
|
|
Exercise Effects in Men & Women on Colon DNA Methylation
|
5R21CA209203-02
|
$191,400
|
|
MCTIERNAN, ANNE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Electronic cigarette use in lung cancer patients
|
1K07CA215546-01A1
|
$138,887
|
|
BRASKY, THEODORE
|
OHIO STATE UNIVERSITY
|
|
DYRK1A signaling in control of cell growth, proliferation and DNA damage repair
|
3R01CA188571-04S1
|
$48,050
|
$48,050
|
LITOVCHICK, LARISA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
DYRK1A signaling in control of cell growth, proliferation and DNA damage repair
|
5R01CA188571-04
|
$341,494
|
$341,494
|
LITOVCHICK, LARISA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis
|
5R33CA204574-02
|
$258,952
|
|
KELLEY, SHANA
|
UNIVERSITY OF TORONTO
|
|
Deubiquitinases in regulation of BRCA1 pathway
|
5R01CA203971-03
|
$363,713
|
|
YUAN, JIAN
|
MAYO CLINIC ROCHESTER
|
|
Defining tolerance mechanisms regulating self-specific T cells
|
5F30CA217109-02
|
$49,524
|
|
LEE, VICTORIA
|
UNIVERSITY OF CHICAGO
|
|
Database and Tools for Functional Inference and Mechanistic Insight into Somatic Cancer Mutations
|
5R01CA204962-02
|
$350,120
|
|
LIANG, JIE
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
CRLF2 signaling in B-cell acute lymphoblastic leukemia
|
5R01CA151898-08
|
$392,969
|
$196,485
|
WEINSTOCK, DAVID
|
DANA-FARBER CANCER INST
|
|
CPRD: UK Resource for Epidemiologic Research
|
ZIA CP010144 10722
|
$362,499
|
$362,499
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
Combating Cetuximab Resistance in Colorectal Cancer
|
5R01CA215093-02
|
$400,637
|
|
ZHANG, YUESHENG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Colorectal Cancer: Characterization of a new Cre-LoxP Model
|
5R03CA216160-02
|
$61,021
|
|
KHARE, SHARAD
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
|
Collaborative Perinatal Project
|
ZIA CP010126 01048
|
$1,119
|
$224
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
COLLABORATIVE HUMAN TISSUE NETWORK EASTERN DIVISION
|
5UM1CA183711-05
|
$1,005,500
|
|
LIVOLSI, VIRGINIA
|
UNIVERSITY OF PENNSYLVANIA
|
|
COG Biospecimen Bank
|
5U24CA196173-04
|
$2,244,903
|
|
RAMIREZ MILAN, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
|
3R01CA118374-10S1
|
$69,420
|
$34,710
|
RYEOM, SANDRA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
|
5R01CA118374-10
|
$342,000
|
$171,000
|
RYEOM, SANDRA
|
UNIVERSITY OF PENNSYLVANIA
|
Total relevant funding to Down Syndrome for this search: $1,626,103
|